Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Peripheral T-cell lymphoma gene expression profiles.

B Martinez-Delgado1

  • 1Human Genetics Group, Centro Nacional de Investigaciones Oncológicas, Madrid, Spain. bmartinez@cnio.es

Hematological Oncology
|May 6, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genome-wide profiling of non-smoking-related lung cancer cells reveals common RB1 rearrangements associated with histopathologic transformation in EGFR-mutant tumors.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

Blood monocyte profiles in COPD patients with PiMM and PiZZ α1-antitrypsin.

Respiratory medicine·2019
Same author

MicroRNA-based molecular classification of non-BRCA1/2 hereditary breast tumours.

British journal of cancer·2013
Same author

Current and future aggressive peripheral T-cell lymphoma treatment paradigms, biological features and therapeutic molecular targets.

Critical reviews in oncology/hematology·2008
Same author

A haplotype containing the p53 polymorphisms Ins16bp and Arg72Pro modifies cancer risk in BRCA2 mutation carriers.

Human mutation·2006
Same author

Differential expression of NF-kappaB pathway genes among peripheral T-cell lymphomas.

Leukemia·2005

DNA microarrays reveal molecular subgroups within peripheral T-cell lymphomas (PTCL), aiding understanding of tumor heterogeneity. Further research is needed to confirm the clinical significance of these PTCL subgroups.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genomics

Background:

  • Peripheral T-cell lymphomas (PTCL) are a complex and heterogeneous group of tumors.
  • Their rarity and complexity have hindered the identification of key molecular events driving their development.
  • Expression profiling using DNA microarrays offers a powerful approach to dissecting tumor biology.

Purpose of the Study:

  • To investigate the molecular heterogeneity of Peripheral T-cell lymphomas (PTCL) using expression profiling.
  • To identify distinct molecular subgroups within PTCL, particularly within the PTCL NOS (not otherwise specified) category.
  • To explore the potential clinical significance of identified molecular subgroups and pathways.

Main Methods:

  • Utilized DNA microarrays for comprehensive gene expression profiling of PTCL samples.

Related Experiment Videos

  • Analyzed expression data to identify molecular subgroups and distinct expression patterns.
  • Investigated the expression levels of genes within the NF-kB pathway.

    • Main Results:

    • Expression profiling revealed significant heterogeneity within PTCL, especially in the PTCL NOS subgroup.
    • Identified distinct molecular subgroups associated with different expression profiles.
    • Differentiated two PTCL subgroups based on NF-kB pathway gene expression, suggesting potential clinical relevance.

    Conclusions:

    • DNA microarrays are instrumental in dissecting the complex expression profiles of PTCL.
    • Molecular sub-classification of PTCL holds promise for better understanding and potentially treating these lymphomas.
    • Further studies with larger cohorts are necessary to validate the clinical significance of identified PTCL subgroups and pathways.